Mayinglong Pharmaceutical Group Co., LTD. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 832.65 million compared to CNY 949.09 million a year ago. Revenue was CNY 832.65 million compared to CNY 949.09 million a year ago.

Net income was CNY 187.61 million compared to CNY 137.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.44 compared to CNY 0.32 a year ago. Diluted earnings per share from continuing operations was CNY 0.44 compared to CNY 0.32 a year ago.